Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,576 | 127 | 96.7% |
| Education | $88.45 | 2 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $862.71 | 45 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $409.54 | 16 | $0 (2024) |
| Incyte Corporation | $294.20 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $250.99 | 5 | $0 (2024) |
| PFIZER INC. | $181.30 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $160.44 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $128.73 | 7 | $0 (2024) |
| Dermavant Sciences, Inc. | $103.91 | 7 | $0 (2024) |
| Lilly USA, LLC | $103.18 | 5 | $0 (2024) |
| GENZYME CORPORATION | $79.92 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,969 | 101 | ABBVIE INC. ($704.10) |
| 2023 | $504.36 | 26 | ABBVIE INC. ($158.61) |
| 2021 | $190.71 | 2 | Regeneron Healthcare Solutions, Inc. ($190.71) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.03 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.26 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Immunology | ||||||
| 11/08/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.04 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.03 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.06 | General |
| Category: Dermatology | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $3.13 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.25 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: Immunology | ||||||
| 10/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.26 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 287 | 447 | $81,526 | $22,199 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 52 | $8,320 | $3,555 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 33 | $7,821 | $3,197 | 40.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 47 | 121 | $24,200 | $3,003 | 12.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,260 | $2,322 | 32.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 24 | 28 | $6,776 | $2,240 | 33.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 29 | 35 | $7,455 | $2,196 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $6,162 | $2,117 | 34.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 37 | 47 | $6,768 | $1,856 | 27.4% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 14 | 29 | $6,148 | $1,436 | 23.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 18 | 56 | $616.00 | $276.61 | 44.9% |
About Cory Pettit
Cory Pettit is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2019. The National Provider Identifier (NPI) number assigned to this provider is 1093277840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cory Pettit has received a total of $2,664 in payments from pharmaceutical and medical device companies, with $1,969 received in 2024. These payments were reported across 129 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,576).
As a Medicare-enrolled provider, Pettit has provided services to 287 Medicare beneficiaries, totaling 447 services with total Medicare billing of $22,199. Data is available for 1 year (2023–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Westerville, OH
- Active Since 04/02/2019
- Last Updated 07/18/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1093277840
Products in Payments
- SKYRIZI (Biological) $438.87
- Sotyktu (Drug) $409.54
- RINVOQ (Biological) $367.32
- DUPIXENT (Biological) $330.91
- OPZELURA (Drug) $294.20
- EUCRISA (Drug) $170.70
- SPEVIGO (Drug) $160.44
- TREMFYA (Drug) $128.73
- VTAMA (Drug) $103.91
- TALTZ (Drug) $103.18
- HUMIRA (Biological) $48.07
- Bimzelx (Biological) $19.88
- ILUMYA (Biological) $17.44
- Zoryve (Drug) $16.03
- CIBINQO (Drug) $10.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Dr. Joshua Grosshandler, M.d, M.D
Dermatology — Payments: $378,447
Jess Demaria, Md, MD
Dermatology — Payments: $195,915
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dr. Kevin Karikomi, D.o, D.O
Dermatology — Payments: $14,525
Jennifer Nash, M.d, M.D
Dermatology — Payments: $9,506